Cost-Effectiveness Analysis of Bevacizumab- Paclitaxel-Carboplatin (PC) Versus PC in First-Line Therapy of Advanced Non-Small Cell Lung Cancer from Patients' Perspective in Vietnam

Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.2276
https://www.valueinhealthjournal.com/article/S1098-3015(14)04206-5/fulltext
Title : Cost-Effectiveness Analysis of Bevacizumab- Paclitaxel-Carboplatin (PC) Versus PC in First-Line Therapy of Advanced Non-Small Cell Lung Cancer from Patients' Perspective in Vietnam
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04206-5&doi=10.1016/j.jval.2014.08.2276
First page : A634
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 1734
Categories :
Tags :
Regions :
ViH Article Tags :